Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBRG
1226
DELISTED
TruBridge
TBRG
| $8.89M | 0.02% |
170,500
+70,400
| +70% | +$3.73M |
|
1227
CACI
CACI
$14.7B
| $8.87M | 0.02% |
83,149
-76,751
| -48% | -$7.18M |
|
1228
CAE Inc. Common Shares
CAE
$8.51B
| $8.83M | 0.02% |
762,300
+378,800
| +99% | +$4.1M |
|
|
AVP
1229
DELISTED
Avon Products, Inc.
AVP
| $8.82M | 0.02% |
1,833,600
+1,392,300
| +315% | +$4.97M |
|
|
APOL
1230
DELISTED
Apollo Education Group Inc Class A
APOL
| $8.81M | 0.02% |
1,072,300
-72,225
| -6% | -$574K |
|
1231
Pembina Pipeline
PBA
$28.6B
| $8.79M | 0.02% |
325,900
-334,664
| -51% | -$7.8M |
|
1232
ManpowerGroup
MAN
$2.73B
| $8.79M | 0.02% |
+107,952
| New | +$8.27M |
|
|
IMPV
1233
DELISTED
Imperva, Inc.
IMPV
| $8.77M | 0.02% |
173,700
-274,600
| -61% | -$13.2M |
|
1234
Power Integrations
POWI
$3.46B
| $8.77M | 0.02% |
353,000
+167,600
| +90% | +$3.86M |
|
|
BONA
1235
DELISTED
BONA FILM GROUP LTD SPONSORED ADS
BONA
| $8.72M | 0.02% |
643,500
+94,000
| +17% | +$1.26M |
|
|
PRSU
1236
Pursuit Attractions and Hospitality Inc
PRSU
$1.31B
| $8.72M | 0.02% |
298,900
+11,000
| +4% | +$310K |
|
|
ARNA
1237
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $8.71M | 0.02% |
442,386
+129,466
| +41% | +$2.08M |
|
|
HNP
1238
DELISTED
Huaneng Power Intl, Inc.
HNP
| $8.69M | 0.02% |
244,500
-22,200
| -8% | -$731K |
|
1239
Lumen
LUMN
$6.67B
| $8.69M | 0.02% |
+271,930
| New | +$7.62M |
|
|
BSTC
1240
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $8.68M | 0.02% |
249,200
-4,167
| -2% | -$153K |
|
|
AVTA
1241
DELISTED
Avantax, Inc. Common Stock
AVTA
| $8.67M | 0.02% |
1,680,600
+468,030
| +39% | +$3.29M |
|
|
NBL
1242
DELISTED
Noble Energy, Inc.
NBL
| $8.65M | 0.02% |
+275,277
| New | +$8.41M |
|
|
WIN
1243
DELISTED
Windstream Holdings Inc
WIN
| $8.63M | 0.02% |
+224,660
| New | +$7.3M |
|
1244
UFP Industries
UFPI
$4.99B
| $8.61M | 0.02% |
300,909
-145,800
| -33% | -$3.47M |
|
|
FXCB
1245
DELISTED
FOX CHASE BANCORP INC COM STK (MD)
FXCB
| $8.6M | 0.02% |
445,300
+44,725
| +11% | +$865K |
|
|
FNGN
1246
DELISTED
Financial Engines, Inc.
FNGN
| $8.57M | 0.02% |
272,801
+264,312
| +3,114% | +$7.33M |
|
1247
Etsy
ETSY
$7.38B
| $8.56M | 0.02% |
983,400
+784,800
| +395% | +$6.28M |
|
1248
DNOW Inc
DNOW
$2.98B
| $8.55M | 0.02% |
+482,300
| New | +$7.42M |
|
|
SVA
1249
DELISTED
Sinovac Biotech, Ltd
SVA
| $8.53M | 0.02% |
1,334,600
-19,500
| -1% | -$117K |
|
1250
Great Southern Bancorp
GSBC
$885M
| $8.52M | 0.02% |
229,500
+45,100
| +24% | +$1.75M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.